• FirefoxInstall the new Firefox »
  •  Dow Up1.49% Nasdaq Up1.15%

    Neurocrine Biosciences Inc. (NBIX)

    -NasdaqGS
    41.53 Up 2.75(7.09%) Mar 30, 4:00PM EDT
    |After Hours : 42.75 Up 1.22 (2.94%) Mar 30, 7:53PM EDT
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):1.8
    Mean Recommendation (last week):1.8
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:47.75
    Median Target:45.00
    High Target:60.00
    Low Target:39.00
    No. of Brokers:8

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Mar 4, 2015BarclaysInitiated Overweight
    Feb 5, 2015Robert W. BairdInitiated Outperform
    Jun 19, 2013OppenheimerInitiated Outperform
    Mar 16, 2012Deutsche BankInitiated Buy
    Aug 9, 2011MKM PartnersInitiated Buy
    Mar 12, 2010Piper JaffrayInitiated Neutral
    Oct 30, 2008Piper JaffrayUpgradeSellNeutral
    Dec 14, 2007Bear StearnsDowngradePeer PerformUnderperform
    Oct 11, 2007WachoviaInitiated Mkt Perform
    Jan 17, 2007Lehman BrothersUpgradeEqual-weightOverweight

    More Upgrades & Downgrades for NBIX

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy2211
    Buy6566
    Hold0000
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.